Private EquityScreenerRefer

MARKET INSIGHTS

  • EventsNEWPrivate market milestones
  • NewsPrecize daily pulse
  • BlogsIn-depth articles and opinions

GUIDES

Explore Now
  • Unlisted SharesStep-by-step · KYC
  • BuyingStep-by-step · KYC
  • SellingExit in 24 - 48 hours
  • Pre-IPOReturns · risks · case studies
  • Tax GuideBudget 2026 changes
  1. Home
  2. Shares
  3. East India Pharmaceutical Works

East India Pharmaceutical Works Unlisted Share Price Today

ISIN INE254X01017.

East India Pharmaceutical Works (EIPW) is one of the oldest pharmaceutical companies in India, with a legacy dating back to 1936. The company is engaged in the manufacturing and marketing of pharmaceutical formulations and healthcare products, including tablets, syrups, drops, and Ayurvedic medicines, catering primarily to the domestic market. Its product portfolio spans analgesics, antibiotics, vitamins, hematinics, gastrointestinal medicines, and herbal formulations, with a focus on afforda…

East India Pharmaceutical Works

Login for availability
East India Pharmaceutical Works

East India Pharmaceutical Works Unlisted Share Price Today

Current Price
Login for availability
Loading chart data...
SectorHealthcare & Pharmaceuticals
ISININE254X01017
Depository
Market Cap₹0.67 Cr
P/E Ratio0.3
ROE (%)3.86
Revenue₹271.68 Cr
Book Value679.17
Debt to Equity0.92
Face Value10
52W HighN/A
52W LowN/A
Market Cap₹0.67 Cr
P/E Ratio0.3
ROE (%)3.86
Revenue₹271.68 Cr
Book Value679.17
Debt to Equity0.92
52W High/LowN/A
Face Value10
As of FY25

About the company & Industry

About Company

East India Pharmaceutical Works (EIPW) is one of the oldest pharmaceutical companies in India, with a legacy dating back to 1936. The company is engaged in the manufacturing and marketing of pharmaceutical formulations and healthcare products, including tablets, syrups, drops, and Ayurvedic medicines, catering primarily to the domestic market. Its product portfolio spans analgesics, antibiotics, vitamins, hematinics, gastrointestinal medicines, and herbal formulations, with a focus on affordable healthcare.

EIPW follows a manufacturing-led, formulation-driven operating model, supported by its facilities at Sarsuna and Durgapur. The company places strategic emphasis on cost-effective production, diversified product portfolio, and domestic distribution reach, rather than high-margin export-led growth. Its performance is closely linked to product demand, working capital management, pricing regulations, and operational efficiency, making scale and cost control critical to profitability.

Headquartered in Kolkata, EIPW primarily operates in the Indian market with a strong legacy presence. The company continues to focus on accessible healthcare solutions, compliance-driven manufacturing, and gradual capacity utilization improvements, positioning itself as a value-focused domestic pharmaceutical player.

About Company

East India Pharmaceutical Works (EIPW) is one of the oldest pharmaceutical companies in India, with a legacy dating back to 1936. The company is engaged in the manufacturing and marketing of pharmaceutical formulations and healthcare products, including tablets, syrups, drops, and Ayurvedic medicines, catering primarily to the domestic market. Its product portfolio spans analgesics, antibiotics, vitamins, hematinics, gastrointestinal medicines, and herbal formulations, with a focus on affordable healthcare.

EIPW follows a manufacturing-led, formulation-driven operating model, supported by its facilities at Sarsuna and Durgapur. The company places strategic emphasis on cost-effective production, diversified product portfolio, and domestic distribution reach, rather than high-margin export-led growth. Its performance is closely linked to product demand, working capital management, pricing regulations, and operational efficiency, making scale and cost control critical to profitability.

Headquartered in Kolkata, EIPW primarily operates in the Indian market with a strong legacy presence. The company continues to focus on accessible healthcare solutions, compliance-driven manufacturing, and gradual capacity utilization improvements, positioning itself as a value-focused domestic pharmaceutical player.

Financials

Margin Pressure

EBITDA Margin declined from 7.6% (FY21) to 4.7% (FY25), indicating sustained pressure on operating profitability.

Consistent Revenue Growth

Revenue increased steadily from ₹172.7 Cr to ₹271.7 Cr (FY21–FY25), reflecting healthy top-line expansion.

Volatile Earnings Trend

PAT fluctuated significantly (₹3.14 Cr → ₹2.2 Cr) with sharp swings in EPS growth, indicating inconsistent bottom-line performance.

Income Statement

Revenue(Figures in Cr.)

Margin Pressure

EBITDA Margin declined from 7.6% (FY21) to 4.7% (FY25), indicating sustained pressure on operating profitability.

Consistent Revenue Growth

Revenue increased steadily from ₹172.7 Cr to ₹271.7 Cr (FY21–FY25), reflecting healthy top-line expansion.

Volatile Earnings Trend

PAT fluctuated significantly (₹3.14 Cr → ₹2.2 Cr) with sharp swings in EPS growth, indicating inconsistent bottom-line performance.

Income Statement

Revenue(Figures in Cr.)

Competitive Position

Market Share

P/E Ratio

Financial Ratio Comparison (FY25)

Particulars
East India Pharmaceutical Works
Albert India Ltd.
Bengal Chemicals & Pharmaceuticals Ltd
Revenue (₹ Cr)271.68345.76119.66
Revenue Growth (%)8.76-4.613.16
EBITDA Margin (%)4.679.4327.59
Net Profit Margin (%)0.814.9717.67
ROE (%)3.864.4411.00
Debt to Equity0.920.020.00
Asset Turnover Ratio (x)1.300.680.45
ROCE (%)-7.19--
ROA (%)12.47--
Fixed Asset Turnover Ratio (x)20.783.531.38
Operating Cash Flow / EBITDA (x)0.48-0.870.26

Market Share

P/E Ratio

Financial Ratio Comparison (FY25)

Particulars
East India Pharmaceutical Works
Albert India Ltd.
Bengal Chemicals & Pharmaceuticals Ltd
Revenue (₹ Cr)271.68345.76119.66
Revenue Growth (%)8.76-4.613.16
EBITDA Margin (%)4.679.4327.59
Net Profit Margin (%)0.814.9717.67
ROE (%)3.864.4411.00
Debt to Equity0.920.020.00
Asset Turnover Ratio (x)1.300.680.45
ROCE (%)-7.19--
ROA (%)12.47--
Fixed Asset Turnover Ratio (x)20.783.531.38
Operating Cash Flow / EBITDA (x)0.48-0.870.26

Management

Shareholding PatternAs of FY26
Promoters
25.87%
Others
74.13%

Key Managerial Personnel

As of FY26
NameDesignation and Experience
Mr. P. Roy
Chairman
Mr. D. Duttagupta
Managing Director

Shareholding PatternAs of FY26
Promoters
25.87%
Others
74.13%

Key Managerial Personnel

As of FY26
NameDesignation and Experience
Mr. P. Roy
Chairman
Mr. D. Duttagupta
Managing Director
Coming Soon

Register to view prices and access exclusive investments.

Minimum ticket ₹10,000 - Start small. No large capital lock-in.
Reserve Access
or
Continue with Google
Reserve Access

FAQs on East India Pharmaceutical Works Unlisted Shares

What is the unlisted share price today?

unlisted share price is updated regularly on Precize. Visit Precize to check price movements and market trends.

How do I buy unlisted shares?

Register on Precize.in, complete KYC, select , enter quantity, and pay via UPI or NEFT. Shares are transferred within 24 hours.

What is 's revenue and profitability?

Please read these important legal notices and disclosures

None of the information displayed on or downloadable from https://www.precize.in represents an offer to buy or sell or a solicitation of an offer to buy or sell any security, nor does it constitute an offer to provide investment advice or service. Registered representatives of precize do not (1) Advise any member on the merits or advisability of a particular investment or transaction, or (2) Assist in the determination of fair value of any security or investment, or (3) Provide legal, tax, or transactional advisory services.

Read more

© 2026 Precize All Rights Reserved.

DECLARATION OF RISKTERMS OF USEPRIVACY POLICY
reported revenue of ₹271.68 Cr in FYFY25. PAT was ₹2.21 Cr. See full financials on this page.

What is the minimum investment for unlisted shares?

Minimum investment for unlisted shares starts from ₹10000. Please log in to view the latest pricing and availability